Back
Zevra Therapeutics Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
67
ZVRA
Zevra Therapeutics
Last Price:
9.63
Seasonality Move:
6.65%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Zevra Therapeutics Stock Forecast
- Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 13.2% based on the past 9 years of stock performance.
- Zevra Therapeutics has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
-
Is Zevra Therapeutics Stock Undervalued?
The current Zevra Therapeutics [ZVRA] share price is $9.59. The Score for ZVRA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal. - ZVRA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Zevra Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 13.2% based on the past 9 years of stock performance.
Zevra Therapeutics Stock Rating
Buy
67
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics overpriced?
- Zevra Therapeutics has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
Zevra Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
zevra.com
52-Week Data
52-Week High:
9.64
52-Week Low:
4.20
Prediction Charts
Market Cap:
511.61M
Price in USD:
9.59
Volume:
677.79K
Beta:
1.81
Technical Analysis
SMA50:
8.19
SMA100:
7.46
SMA200:
6.36
52-Wk Change:
115.88%
Stock Predictions
-
Is Zevra Therapeutics stock public?
Yes, Zevra Therapeutics is a publicly traded company. -
What is the Zevra Therapeutics stock quote today?
The Zevra Therapeutics stock price is 9.59 USD today. -
How to buy Zevra Therapeutics stock online?
You can buy Zevra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-5 | 8.54 | 8.61 | 8.65 | 8.26 |
| Nov-6 | 8.70 | 8.80 | 8.91 | 8.60 |
| Nov-7 | 8.88 | 8.81 | 9.03 | 8.67 |
| Nov-8 | 8.81 | 9.00 | 9.04 | 8.65 |
| Nov-11 | 9.02 | 8.95 | 9.04 | 8.76 |
| Nov-12 | 8.91 | 8.57 | 9.09 | 8.35 |
| Nov-13 | 8.08 | 8.64 | 8.80 | 7.84 |
| Nov-14 | 8.35 | 9.03 | 9.21 | 8.35 |
| Nov-15 | 9.10 | 8.62 | 9.17 | 8.32 |
| Nov-18 | 8.62 | 8.60 | 8.69 | 8.33 |
| Nov-19 | 8.60 | 8.97 | 9.13 | 8.53 |
| Nov-20 | 9.09 | 8.97 | 9.27 | 8.71 |
| Nov-21 | 9.04 | 9.13 | 9.30 | 8.90 |
| Nov-22 | 9.24 | 9.59 | 9.64 | 9.15 |
Zevra Therapeutics Earnings
Zevra Therapeutics Earnings Report: Per Share Zevra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Zevra Therapeutics Forecast Revenue Growth
Zevra Therapeutics Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and an increase next year of $1.62 per share.
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.